CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.8611
-0.0189 (-2.15%)
At close: Sep 4, 2026, 4:00 PM EDT
0.8610
-0.0001 (-0.01%)
After-hours: Sep 4, 2026, 6:04 PM EDT
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $10.19 million as of September 4, 2026. Its market cap has decreased by -54.72% in one year.
Market Cap
10.19M
Enterprise Value
8.94M
1-Year Change
-54.72%
Ranking
Category
Stock Price
$0.86
ChartMarket Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $10.19M, a decrease of -77.91%. That is a compound annual growth rate of -35.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 10.19M | -33.86% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiora Pharmaceuticals | 11.28M |
| Daré Bioscience | 11.02M |
| Xenetic Biosciences | 10.94M |
| Azitra | 10.88M |
| GT Biopharma | 10.87M |
| Lunai Bioworks | 10.84M |
| Vistagen Therapeutics | 10.77M |
| Senti Biosciences Holdings | 10.36M |